Hair loss affects 3–5% of GLP-1 RA users but is usually telogen effluvium from rapid weight loss, not the drug itself. Learn the timeline, causes, and evidence-based minimization strategies.
Hair loss affects 3–5% of GLP-1 RA users but is usually telogen effluvium from rapid weight loss, not the drug itself. Learn the timeline, causes, and evidence-based minimization strategies.